| Generation of custom polyclonal antisera. |
Peptide yielded no phospho-antibodies/very low number of phospho-antibodies. |
The peptide designed had an internal cysteine that was used for conjugation. |
An internal cysteine should not be used to conjugate the peptide to hapten for injection, since that will mask the phospho-epitope and result in antibodies that will be very difficult, if not impossible to resolve. Thus, in cases where there may be a cysteine right next to the phospho-epitope, there are better chances of obtaining an antibody of interest by making slightly longer peptides (11-14 mers) and obtaining them from the vendor in a reduced state, such that they do not form internal di-sulfide bonds. |
| Generation of custom polyclonal antisera. |
The sera produced low titer against the phospho-antigen. |
The region of the peptide used was low complexity |
Anecdotally, we have found that different species of animals sometimes give different results in titer generation. Thus, using more than one animal species may be useful. Or, use 5-10 fold more sera with the same volume of the column (step 5 on) for purification |
| 22 |
Conjugaton of BSA with peptide did not go to completion. |
Inefficient or failed conjugation can occur if the quantity of peptide used is incorrect, if the peptide and/or BSA is not fully dissolved or if a wrong solution is used in the conjugation. |
Ensure that the peptide is dissolved completely. |
|
|
The peptide did not dissolve efficiently. |
Add DMSO to the peptide (at 10%) dissolve. Spin out what has not dissolved. Then re-dissolve this in fresh conjugation buffer, with 10% DMSO and repeat until there is no precipitate left. Pool all the dialyzed samples. |
|
|
Conjugation Buffer was not used to dissolve the peptide |
Use the conjugation buffer supplied with the kit |
|
|
Conjugation Buffer has precipitates |
Check the date on which the kit was bought and ensure that it has not been at 4C for too long. |
|
|
The conjugation reaction was not allowed to continue for 2 hours at room temperature |
Incubate the peptide∷BSA mix at room temperature for 2 hours |
| 22, 41, 64 |
Conjugation of peptide∷BSA complex did not go to completion/was not in right ratio with Sepharose. |
The peptide∷BSA complex was in excess to the Sepharose beads. |
Ensure that the peptide∷BSA complex is added in a ration of 2mg of the compelx to 1mg of Sephaorse. |
|
|
The peptide∷BSA complex and Sephaorse mix dried in the column. |
Ensure that there is enough coupling buffer such that the beads do not dry out. |
| 73, 139 |
The pH of the collected Glycine eluted antibodies is not neutral. |
The 1M Tris used for neutralization was pHed to a pH of 8. |
Use 1M Tris that has not been pHed. This allows for the hydroxyl ions to neutralize the strong acidic Glycine solution. |
| 82, 93 |
There are no IgG fractions upon elution from the phospho-peptide column |
Peptide design was flawed, refer to generation of custom polyclonal antisera. |
|
|
|
Instead of using the flow through from the non-phospho peptide column, the elution from the non-phospho peptide column was used for binding to the phospho-peptide column. |
Ensure that the FLOW THROUGH from the non-phospho peptide column is the one used to pass over the phospho-peptide column. |
|
|
The phospho-peptide column was not washed thoroughly and coupled during preparation with the coupling buffer and wash buffer, resulting in some phospho-peptides coming off the column during antibody elution. |
Prepare the phospho-peptide column again, with care taken to follow each step of the protocol. |
|
|
The secondary used for blotting is old, and does not work. |
Use a positive control sample to ensure that the secondary antibody works. |
|
|
ECL kit used was left out at room temperature and the reagent is not optimal. |
Use a positive control sample to ensure that the ECL reagent is optimally functioning. |
| 93 |
The phospho-peptide antibody preparation also recognizes the non-phosph-peptide. |
Refer to Figure 1 for possible options for the types of antibodies that can be generated from the phospho-peptide immunogen. |
Pass the antibody back over the non-phospho-peptide column, collect flow through that is then passed over the phospho-peptide column. |